Physician profile

Brian Cobb

Obstetrics & Gynecology · Tripler Army Medical Center, HI

NPI 1124036280

$395.30

in general payments reported to CMS, 2019-2025

12 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$12.76

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $150.99 2019-2022
Allergan, INC. $57.92 2019-2020
Merck Sharp & Dohme LLC $46.05 2019
Zyla Life Sciences, INC. $23.54 2019
Intuitive Surgical, INC. $18.92 2022
Ascend Therapeutics US, LLC $16.60 2019
Therapeuticsmd, INC. $15.49 2019
Bayer Healthcare Pharmaceuticals INC. $14.46 2020
Daiichi Sankyo INC. $13.63 2019
Organon LLC $12.76 2024
Covidien LP $12.71 2019
Hologic Sales and Service, LLC $12.23 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brian Cobb

$395.30

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/322414/brian-cobb

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.